5 millionpatients have been evaluated with the NCstat System

Over 1.5 millionpatients have been evaluated with the NC-stat System. NeuroMetrix presentlymarkets pre-configured electrode arrays for 6 commonly tested nerves Dr. Gozani added, "This CPT code, when issued, may improve our NC-statcustomers ability to submit claims efficiently and for these claims to beprocessed expeditiously. We believe that use of this new CPT code may streamlinethe process for obtaining reimbursement for nerve conduction studies performedusing the NC-stat System." The Company expects that the new code will be published in the Federal Registerin the Fall of 2009 for implementation January 1, 2010. About CPT Coding In developing new and revised Category I CPT codes the CPT Editorial Panelrequires, among other things: that the service/procedure receive approval from the Food and DrugAdministration (FDA) for the specific use of devices or drugs; that the service/procedure is performed across the country in multiplelocations; that many physicians or other health care professionals perform theservice/procedure; and that the clinical efficacy of the service/procedure has been well establishedand documented.Following a decision of the CPT Editorial Panel, specialty societies conductsurveys of member physicians who perform the service described by the new codeto establish recommendations for the work Relative Value Units (RVUs) and thedirect practice expense inputs for the new code.

These RVUs are based on theamount of time a service takes to perform and the intensity of that service ascompared to other procedures across specialties. The consensus recommendationsare then forwarded to the AMA / Specialty Society Relative Value Scale UpdateCommittee (RUC) where they will be accepted or modified. The RUCsrecommendations are forwarded to the Centers for Medicare & Medicaid Services(CMS), which typically accepts over 95 of RUC recommendations. CMS determinesthe practice expense and professional liability RVUs and then publishes thefinal RVUs in the Federal Register - usually in October for implementationJanuary 1 the next year. The amount of reimbursement from Medicare thatphysicians will receive for performing the described service is then based onthese final RVUs. More information about CPT codes and the process ofestablishing those codes is available at the AMA's website: About NeuroMetrix NeuroMetrix is a science-based medical device company advancing patient carethrough the development and marketing of innovative medical device products thataid physicians in the assessment and treatment of diseases and injuries ofperipheral nerves, and that provide regional anesthesia and pain control.

Our product pipeline includes a system designed to precisely deliverpharmacologic agents such as anesthetics and corticosteroids in close proximityto nerves ("perineurally") for regional anesthesia, pain control and thetreatment of focal neuropathies such as carpal tunnel syndrome. We are alsodeveloping products for intra-operative peripheral nerve assessment andmonitoring, and a neurostimulation based product that promotes nerve fiberregeneration for the treatment of acute nerve injuries such as those resultingfrom lacerations or other forms of trauma. The statements contained in this press release include forward-lookingstatements within the meaning of Section 27A of the Securities Act of 1933, asamended, and Section 21E of the Securities Exchange Act of 1934, as amended,including, without limitation, statements regarding NeuroMetrixs or itsmanagements expectations, hopes, beliefs, intentions or strategies regardingthe future. The words "believe," "may," "will," "estimate," "continue,""anticipate," "intend," "expect," "plan," "hope" and similar expressions mayidentify forward-looking statements, but the absence of these words does notmean that a statement is not forward-looking. The forward-looking statementscontained in this press release are based on NeuroMetrixs current expectationsand beliefs concerning future developments and their potential effects on it.There can be no assurance that future developments affecting NeuroMetrix will bethose that NeuroMetrix has anticipated.

These forward-looking statements involvea number of risks, uncertainties (some of which are beyond NeuroMetrixscontrol) or other assumptions that may cause actual results or performance to bematerially different from those expressed or implied by these forward-lookingstatements. These risks and uncertainties include, but are not limited to, risksand uncertainties associated with: the AMA CPT Editorial Panel process,including the possibility that this Panel reconsiders its decision regarding theestablishment of a Category I CPT code for nerve conduction studies performedwith pre-configured electrode arrays prior to its publication; the process forestablishing the reimbursement amount under this new Category I CPT code,including the possibility that the amount determined may be lower than thereimbursement amount under existing CPT codes for nerve conduction studies;continued uncertainty regarding reimbursement from third-party payers other thanMedicare and Medicaid; the pending 510(k) filing with the United States Food andDrug Administration relating to portions of the onCall Information System thatare currently in use for the NC-stat System, including the possibility thatNeuroMetrix may be required to modify or remove the aspects of the onCallInformation System that are under review, which may make use of the NC-statSystem by physicians more time consuming; and the risks and uncertaintiesdescribed under the heading "Item 1A Risk Factors" in NeuroMetrixs AnnualReport on Form 10-K for the fiscal year ended December 31, 2007 or inNeuroMetrixs other filings with the Securities and Exchange Commission. Shouldone or more of these risks or uncertainties materialize, or should any ofNeuroMetrixs assumptions prove incorrect, actual results may vary in materialrespects from those projected in these forward-looking statements. NeuroMetrixundertakes no obligation to update or revise any forward-looking statements,whether as a result of new information, future events or otherwise, except asmay be required under applicable securities laws. ) Desperate to make amends for its 1-6 bowl performance and reverse its reputation as a degenerating football conference, this is not where the Big Ten expected to be.As college football reaches the meat of the league schedule, computer master and BCScontributor Jeff Sagarin ranks the Big Ten last among the six major conferences.Sagarin Conference Ratings1 SEC2 Pac-103 ACC4 Big125 Big East6 Big Ten7 I-A Independents8 Mountain West9 WAC10. CUSAWhen you consider the fact that to date, the Big Ten's signature win is Michigan at home over Notre Dame, it's easy to understand why.What has to be even more discouraging for the conference is the lack of marquee opportunities remaining. Between the 11 programs, there are only 10 non-conference games left in 2009.